Mount Sinai Hospital
New York, 10021, United States
NCT Number: NCT07222501
Aim 2: Conduct a pilot RCT of SaMBA-WTC to determine feasibility and preliminary impact in preparation for a fully powered trial. (7M-24M) The investigators will conduct a pilot RCT (n=58) of the SaMBA-WTC model vs. an attention control. Data will be collected on the primary outcomes (asthma control [asthma control test, ACT], medication use, inhaler technique) as well as on other secondary outcomes including measures of physical function, self-management behaviors, feasibility and fidelity at baseline, at intervention completion at 3 months, and for sustainability at 6 months. This project will prepare the team for all aspects of a subsequent larger efficacy trial of SaMBA-WTC.
This study is active but is not currently recruiting participants.
21 year and older
All sexes
Observational
New York, 10021, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The health coach will ask many questions to determine how best to help asthma management and to improve asthma control. The intervention lasts 3 months. During those 3 months, the health coach will speak with participant by phone or video chat several times. Meetings will occur once a week for the first 2-3 weeks, then every 2-4 weeks until the intervention ends. The days and times of the meetings will be up to the participant.
Other names: Supporting Self-Management Behaviors for Adults
1-3 visits with an asthma educator to receive basic asthma education
Time frame: 12 months and 3 months post intervention
Asthma control test assesses how well asthma is controlled over the past four weeks. Total score range from 5-25, with higher score indicating better health outcomes.
Time frame: 12 months and 3 months post intervention
Medication use will be measured with electronic monitors attached to the participant's control inhaler. Adherence will be measured by use of the electronic monitors that will capture how often the participant uses their controller inhaler.
Time frame: 12 months and 3 months post intervention
The validated Mini Asthma Quality of Life Questionnaire (AQLQ) is available in English and Spanish. The 15-item questionnaire measures quality of life in the domains of symptoms, activity limitation, emotional function, and environmental stimuli. Items are scored on a 7-point scale from severely impaired to not impaired at all. Each domain scores and full scores range 1-7, with higher scores indicating better quality of life.
Time frame: 12 months and 3 months post intervention
Any hospital visits at every research visit will be track by use of survey in REDCap.
Time frame: 12 months and 3 months post intervention
Any emergency visits at every research visit will be track by use of survey in REDCap.
Icahn School of Medicine at Mount Sinai
Other
Comprehensive Self-Management Support for WTC Responders With Asthma
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03953300
Asthma, Bronchial Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT05059210
Asthma, Bronchial Diseases
Charlotte, North Carolina, United States
View Trial DetailsNCT06052267
Asthma, Bronchial Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT06948396
Asthma, Bronchial Diseases
Cittadella (PD), Padova, Italy
View Trial Details